StemCyte International, Ltd. (TPE:4178)

StemCyte International Revenue

StemCyte International had revenue of 87.81M TWD in the quarter ending March 31, 2026, a decrease of -11.29%. This brings the company's revenue in the last twelve months to 357.74M, down -8.50% year-over-year. In the year 2025, StemCyte International had annual revenue of 368.91M, down -3.60%.

• Revenue (ttm): 357.74M
• Revenue Growth: -8.50%
• P/S Ratio: 10.95
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 3.92B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	368.91M	-13.77M	-3.60%
Dec 31, 2024	382.69M	19.91M	5.49%
Dec 31, 2023	362.78M	15.09M	4.34%
Dec 31, 2022	347.69M	-509.38M	-59.43%
Dec 31, 2013	857.07M	124.33M	16.97%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 23, 2026

Data Sources Report a data error